Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bioscience Equity Partners (BEP) is a life sciences investment bank and fund manager founded in 2020, with roots tracing back to 2005. The firm operates from multiple global financial and innovation hubs, including New York, Dubai, Sydney, and London. BEP focuses on providing venture capital and funding solutions to early-stage companies in the biotech, med tech, and digital health sectors.
Since its inception, BEP has positioned itself as a key player in the life sciences investment space, emphasizing transformative technologies that can significantly impact healthcare. The firm combines venture capital investments with comprehensive investment banking services, including mergers and acquisitions, capital placements, and strategic advisory tailored to the complexities of the life sciences sectors.
Bioscience Equity Partners invests in early-stage companies within the life sciences sector, specifically targeting biotech, med tech, and digital health. The firm provides a combination of venture capital and investment banking services, aiming to support transformative technologies that have the potential to shape the future of healthcare. Their investment banking services encompass mergers and acquisitions, capital placements, and strategic advisory tailored to the complexities of the life sciences sectors.
Geographically, BEP operates globally, with a strong presence in North America, Europe, Asia, and the Middle East. The firm typically engages in pre-seed, seed, and seed+ (extension) stages, focusing on companies that demonstrate innovative approaches and solutions in healthcare. BEP seeks to partner with founders who are committed to advancing healthcare through technology and innovation.
To pitch to Bioscience Equity Partners, founders should send an email to info@bioscienceequity.com. A well-structured pitch deck is essential, including details about the business model, market opportunity, and team qualifications. Response times may vary, so founders should be prepared for potential follow-up discussions.
On January 29, 2026, Bioscience Equity Partners published a blog post titled "Is AI Really Changing Biotech Investing or Is It Mostly Hype?" This post reflects their engagement with current trends in the biotech sector, particularly the impact of artificial intelligence on investment strategies.
Additionally, on January 6, 2026, BEP was nominated for the Global Startup Awards as Investor of the Year, highlighting their recognition within the industry for their contributions to early-stage life sciences investments.
What are the investment criteria for Bioscience Equity Partners?
Bioscience Equity Partners focuses on early-stage companies in the life sciences sector, particularly in biotech, med tech, and digital health. They look for transformative technologies that can significantly impact healthcare.
How can I apply or pitch to Bioscience Equity Partners?
Founders can reach out via email at info@bioscienceequity.com to discuss potential investment opportunities. A detailed pitch deck outlining the business model, market potential, and team background is recommended.
What makes Bioscience Equity Partners different from other investors?
Bioscience Equity Partners combines venture capital with investment banking services, providing a unique approach to supporting early-stage life sciences companies. Their expertise in mergers and acquisitions and strategic advisory adds significant value to their portfolio companies.
What is the geographic scope of Bioscience Equity Partners?
Bioscience Equity Partners operates globally, with a presence in key financial and innovation hubs across North America, Europe, the Middle East, and the Asia-Pacific region.
What is the typical check size for investments?
While specific check sizes are not disclosed, BEP focuses on early-stage investments, which typically range from pre-seed to seed+ funding rounds.
What kind of post-investment involvement can founders expect?
Bioscience Equity Partners provides operational support, strategic advisory, and access to their network, helping portfolio companies navigate the complexities of the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.